US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist
  • 13.070
  • +0.540+4.31%
Close Jun 3 16:00 ET
  • 13.700
  • +0.630+4.82%
Post 19:54 ET
563.52MMarket Cap-7421P/E (TTM)

Kyverna Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-122.77%-25.53M
-45.13%-52.41M
-110.54%-18.56M
-11.46M
-63.00%-36.11M
-8.82M
-22.16M
Net income from continuing operations
-139.55%-26.69M
-108.93%-60.37M
-143.26%-20.67M
---11.14M
-9.65%-28.89M
---8.5M
---26.35M
Operating gains losses
----
----
----
----
----
----
--21K
Depreciation and amortization
22.34%482K
62.42%1.71M
23.53%462K
--394K
79.35%1.05M
--374K
--586K
Other non cash items
36.98%526K
21.90%1.72M
8.35%454K
--384K
70.21%1.41M
--419K
--829K
Change In working capital
-23.94%-1.84M
133.16%3.42M
176.91%1.01M
---1.48M
-129.95%-10.33M
---1.31M
---4.49M
-Change in prepaid assets
-1,498.14%-2.57M
-31.13%-1.19M
-207.81%-985K
---161K
-25.90%-909K
---320K
---722K
-Change in payables and accrued expense
383.52%1.55M
908.85%5.48M
472.09%3.94M
---546K
-131.46%-678K
--688K
--2.16M
-Change in other current assets
32.64%-293K
-190.27%-1.85M
-214.58%-1.81M
---435K
-1,533.33%-637K
---576K
---39K
-Change in other current liabilities
-52.49%-520K
191.00%981K
84.18%-130K
---341K
-372.81%-1.08M
---822K
---228K
-Change in other working capital
----
----
----
----
-24.18%-7.03M
---282K
---5.66M
Cash from discontinued investing activities
Operating cash flow
-122.77%-25.53M
-45.13%-52.41M
-110.54%-18.56M
---11.46M
-63.00%-36.11M
---8.82M
---22.16M
Investing cash flow
Cash flow from continuing investing activities
-999.88%-122.88M
37.68%-8.79M
109.16%31.68M
13.66M
-993.64%-14.1M
15.15M
-1.29M
Net PPE purchase and sale
-1,839.29%-543K
19.14%-621K
-2,683.33%-334K
---28K
40.42%-768K
---12K
---1.29M
Net investment purchase and sale
-994.07%-122.34M
38.75%-8.16M
111.19%32.02M
--13.68M
---13.33M
--15.16M
--0
Cash from discontinued investing activities
Investing cash flow
-999.88%-122.88M
37.68%-8.79M
109.16%31.68M
--13.66M
-993.64%-14.1M
--15.15M
---1.29M
Financing cash flow
Cash flow from continuing financing activities
234,856.25%338.05M
389.21%58.12M
-1,305.88%-1.43M
-144K
-83.62%11.88M
-102K
72.52M
Net issuance payments of debt
-37.50%-231K
-213.65%-781K
-51.03%-219K
---168K
-507.32%-249K
---145K
---41K
Net common stock issuance
--341.17M
----
----
--0
----
----
----
Net preferred stock issuance
----
401.09%59.9M
--0
----
-83.52%11.95M
--0
--72.53M
Proceeds from stock option exercised by employees
166.67%64K
268.57%645K
539.53%275K
--24K
483.33%175K
--43K
--30K
Net other financing activities
---2.96M
---1.65M
---1.49M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
234,856.25%338.05M
389.21%58.12M
-1,305.88%-1.43M
---144K
-83.62%11.88M
---102K
--72.52M
Net cash flow
Beginning cash position
-8.04%35.21M
-50.03%38.29M
-26.61%23.53M
--38.29M
178.21%76.62M
--32.06M
--27.54M
Current changes in cash
9,137.46%189.65M
91.97%-3.08M
87.60%11.68M
--2.05M
-178.10%-38.33M
--6.23M
--49.08M
End cash Position
457.38%224.86M
-8.04%35.21M
-8.04%35.21M
--40.34M
-50.03%38.29M
--38.29M
--76.62M
Free cash flow
-126.95%-26.07M
-43.79%-53.03M
-114.03%-18.9M
---11.49M
-57.32%-36.88M
---8.83M
---23.44M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -122.77%-25.53M-45.13%-52.41M-110.54%-18.56M-11.46M-63.00%-36.11M-8.82M-22.16M
Net income from continuing operations -139.55%-26.69M-108.93%-60.37M-143.26%-20.67M---11.14M-9.65%-28.89M---8.5M---26.35M
Operating gains losses --------------------------21K
Depreciation and amortization 22.34%482K62.42%1.71M23.53%462K--394K79.35%1.05M--374K--586K
Other non cash items 36.98%526K21.90%1.72M8.35%454K--384K70.21%1.41M--419K--829K
Change In working capital -23.94%-1.84M133.16%3.42M176.91%1.01M---1.48M-129.95%-10.33M---1.31M---4.49M
-Change in prepaid assets -1,498.14%-2.57M-31.13%-1.19M-207.81%-985K---161K-25.90%-909K---320K---722K
-Change in payables and accrued expense 383.52%1.55M908.85%5.48M472.09%3.94M---546K-131.46%-678K--688K--2.16M
-Change in other current assets 32.64%-293K-190.27%-1.85M-214.58%-1.81M---435K-1,533.33%-637K---576K---39K
-Change in other current liabilities -52.49%-520K191.00%981K84.18%-130K---341K-372.81%-1.08M---822K---228K
-Change in other working capital -----------------24.18%-7.03M---282K---5.66M
Cash from discontinued investing activities
Operating cash flow -122.77%-25.53M-45.13%-52.41M-110.54%-18.56M---11.46M-63.00%-36.11M---8.82M---22.16M
Investing cash flow
Cash flow from continuing investing activities -999.88%-122.88M37.68%-8.79M109.16%31.68M13.66M-993.64%-14.1M15.15M-1.29M
Net PPE purchase and sale -1,839.29%-543K19.14%-621K-2,683.33%-334K---28K40.42%-768K---12K---1.29M
Net investment purchase and sale -994.07%-122.34M38.75%-8.16M111.19%32.02M--13.68M---13.33M--15.16M--0
Cash from discontinued investing activities
Investing cash flow -999.88%-122.88M37.68%-8.79M109.16%31.68M--13.66M-993.64%-14.1M--15.15M---1.29M
Financing cash flow
Cash flow from continuing financing activities 234,856.25%338.05M389.21%58.12M-1,305.88%-1.43M-144K-83.62%11.88M-102K72.52M
Net issuance payments of debt -37.50%-231K-213.65%-781K-51.03%-219K---168K-507.32%-249K---145K---41K
Net common stock issuance --341.17M----------0------------
Net preferred stock issuance ----401.09%59.9M--0-----83.52%11.95M--0--72.53M
Proceeds from stock option exercised by employees 166.67%64K268.57%645K539.53%275K--24K483.33%175K--43K--30K
Net other financing activities ---2.96M---1.65M---1.49M----------------
Cash from discontinued financing activities
Financing cash flow 234,856.25%338.05M389.21%58.12M-1,305.88%-1.43M---144K-83.62%11.88M---102K--72.52M
Net cash flow
Beginning cash position -8.04%35.21M-50.03%38.29M-26.61%23.53M--38.29M178.21%76.62M--32.06M--27.54M
Current changes in cash 9,137.46%189.65M91.97%-3.08M87.60%11.68M--2.05M-178.10%-38.33M--6.23M--49.08M
End cash Position 457.38%224.86M-8.04%35.21M-8.04%35.21M--40.34M-50.03%38.29M--38.29M--76.62M
Free cash flow -126.95%-26.07M-43.79%-53.03M-114.03%-18.9M---11.49M-57.32%-36.88M---8.83M---23.44M
Currency Unit USDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Recent IPOs
Recent IPOs
Intraday-0.93%